Cryterion Medical, Inc.
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Cryterion Medical, Inc.
Deal Watch: Novo Nordisk Builds On Metabolic Strength Acquiring Partner Embark
Bristol and Regeneron sign separate cell therapy technology pacts, plus deals involving Takeda/ImmunoGen, Serina/AgeX, Cybin/Small Pharma, Taiho/Phost’in, Royalty/Ferring and Aardvark/GRI Bio.
MTI Top 100: Leading Medtechs See Steady Organic Growth In A Market On The Cusp Of Change
The disruptive medtech M&A of recent years was not matched in the past year for volume, but there were isolated outbreaks of major activity, as shown in our company rankings.
Boston Scientific Gulps Down Claret After Cryterion, In Double-Whammy July
Boston Scientific has inked a deal of up to $270m for embolic protection system developer Claret Medical, marking its second acquisition in the space of two weeks.
Deals Update
A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.
Company Information
- Industry
-
Medical Devices
- Rehabilitation Equipment and Devices
- Surgical Equipment & Devices
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice